URIC ACID

The Uric Acid blood test measures the concentration of uric acid in the blood. Uric acid is a natural waste product formed when the body breaks down purines, which are substances found in the body's cells and in certain foods and beverages. Most uric acid dissolves in the blood, passes through the kidneys and is removed from the body in urine.

When the body produces excessive uric acid or the kidneys cannot remove it efficiently, the concentration in the blood may increase. This condition is called hyperuricemia. Persistently elevated uric acid may contribute to the formation of needle-shaped urate crystals in and around the joints, potentially resulting in gout. Excess uric acid may also contribute to certain kidney stones. However, an elevated uric acid result alone does not confirm gout, and many people with hyperuricemia never develop symptoms.

The test may be requested for people experiencing sudden joint pain, swelling, redness or warmth, particularly when the big toe, ankle or knee is affected. It may also be used to monitor people receiving treatment for gout or certain cancer treatments that can rapidly increase uric acid. Results must be interpreted with symptoms, medical history, medicines, kidney function and other relevant investigations.

Benefits of the Test

• Measures the concentration of uric acid in the bloodstream.
• Supports the evaluation of suspected hyperuricemia and gout.
• Helps assess whether abnormal uric acid may be contributing to kidney stones.
• Supports monitoring of uric acid-lowering treatment in people with gout.
• Helps monitor patients receiving chemotherapy or other treatments that cause rapid cell breakdown.
• Provides useful information when assessed with kidney function tests and other metabolic investigations.
• May help doctors determine whether further testing or treatment is required.

Why Doctors Recommend This Test

A doctor may recommend a Uric Acid test when a person has symptoms that could indicate gout. A gout attack frequently causes sudden and severe pain in one joint, commonly the joint at the base of the big toe. The affected joint may become swollen, red, warm and extremely sensitive. Gout may also affect the ankles, knees, fingers, wrists or elbows.

The test may be requested for people who have experienced recurrent kidney stones, especially when uric acid stones are suspected. It may be assessed alongside creatinine, blood urea, urine analysis and imaging studies to obtain a broader understanding of kidney health. A blood uric acid result cannot independently determine the composition of a kidney stone.

Uric acid monitoring may be important before and during chemotherapy for leukaemia, lymphoma or other cancers with a high tumour burden. Rapid destruction of cancer cells can release large quantities of purines, leading to a sudden increase in uric acid and a serious complication called tumour lysis syndrome. Monitoring helps healthcare professionals identify changes early and provide appropriate preventive or therapeutic management.

Doctors may also request the test for people taking medicines that influence uric acid, including certain diuretics, low-dose aspirin and some immunosuppressive or cancer medicines. It may form part of an assessment for kidney dysfunction, metabolic abnormalities or unexplained joint symptoms.

Preparation Before Test

A venous blood sample is collected, usually from a vein in the arm. Preparation requirements can differ between laboratories and according to other tests ordered at the same time. Fasting may not always be required for an isolated serum uric acid test. Follow the specific instructions provided by the doctor or collection centre. If fasting is advised, only plain water should generally be consumed during the instructed fasting period.

Inform the doctor about all prescribed medicines, over-the-counter medicines, vitamins and supplements. Aspirin, diuretics, niacin, chemotherapy medicines and several other treatments may influence uric acid results. Do not stop or change any prescribed medicine unless instructed by the treating doctor.

Tell the healthcare professional about recent illness, intense exercise, dehydration, alcohol consumption, major dietary changes, kidney disease, gout treatment or cancer therapy. These factors may affect the interpretation of the result. Maintaining normal hydration is generally appropriate unless fluid intake has been restricted for medical reasons.

A single high-purine meal does not necessarily represent the person's usual uric acid status, but frequent consumption of organ meats, red meat, certain seafood, alcohol and fructose-sweetened beverages may contribute to elevated levels in susceptible individuals. Patients should not make extreme dietary changes immediately before testing unless specifically advised.

Normal Reporting Time

The Uric Acid blood test is commonly reported on the same day or within 24 hours after the laboratory receives the sample. Actual turnaround time may vary according to the collection time, laboratory workload, analyser availability, quality-control procedures and the need to verify an unexpected result.

Urgent monitoring during cancer treatment or suspected tumour lysis syndrome may be processed more quickly when requested by the treating medical team. Patients should contact the laboratory or healthcare provider if a report is required for an urgent clinical decision.

Who Should Take This Test?

The Uric Acid test may be appropriate for people with sudden or recurrent joint pain, redness, warmth and swelling suggestive of gout. It may also be recommended for people previously diagnosed with gout to monitor uric acid-lowering therapy and help the doctor assess whether the treatment target is being achieved.

People with recurrent kidney stones, kidney dysfunction or risk factors for uric acid accumulation may also require testing. Monitoring can be important for patients with leukaemia, lymphoma, multiple myeloma or other cancers, particularly before and during chemotherapy or treatments that cause rapid destruction of tumour cells.

The test may be requested for people taking medicines known to alter uric acid levels or those with medical conditions associated with increased production or reduced elimination of uric acid. Routine testing is not required for every person without symptoms or risk factors. The decision should be based on medical history, clinical findings and professional advice.

Detailed Information

Purines are broken down primarily in the liver, producing uric acid as an end product. Uric acid circulates in the blood and is removed mainly by the kidneys, with a smaller amount eliminated through the digestive system. Blood uric acid can rise when production increases, kidney excretion decreases or both processes occur together.

Hyperuricemia may occur with reduced kidney function, dehydration, obesity, metabolic disorders, psoriasis, rapid cell turnover, certain cancers, chemotherapy, alcohol consumption, a high-purine diet or medicines such as some diuretics. Genetic factors can also influence how the body produces and removes uric acid.

When uric acid remains above its saturation point, monosodium urate crystals may form. Crystal deposition in a joint can trigger intense inflammation and produce a gout attack. Long-standing crystal accumulation may lead to firm deposits called tophi around joints and soft tissues. Urate crystals can also contribute to kidney stone formation or kidney-related complications in susceptible patients.

A high blood uric acid result does not automatically mean that a person has gout. Some people have elevated levels without symptoms, while a person experiencing an acute gout attack may occasionally have a result within the laboratory reference interval. When gout remains uncertain, examination of fluid taken from the affected joint for urate crystals may provide more direct diagnostic evidence.

Low uric acid levels are less common and may occur because of certain medicines, reduced production, severe liver disease or conditions that increase uric acid loss through the kidneys. A low result must be evaluated in its clinical context and does not establish a specific diagnosis by itself.

Reference intervals can vary according to the laboratory's method, units, age, sex and local population. Patients should use the reference interval printed on their own report rather than comparing the result with a general value found elsewhere. For people receiving treatment for gout, the doctor's therapeutic target may differ from the laboratory's general reference interval.

Further evaluation of an abnormal result may include kidney function tests, urine analysis, a 24-hour urine uric acid test, joint-fluid analysis or imaging. Treatment decisions should not be based on one laboratory result alone. A healthcare professional should interpret the result using symptoms, previous results, medicines, diet, alcohol intake, kidney function and relevant medical conditions.